NINTEDANIB ESYLATE
Generic: NINTEDANIB ESYLATE
Macleods Pharmaceuticals LimitedManufacturer
ORALRoute
NINTEDANIB ESYLATEActive Substance
2026-08-03Original Approval
NINTEDANIB ESYLATE is FDA application ANDA219926, sponsored by MACLEODS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
937 reports
2
DEATH
572 reports
3
NAUSEA
358 reports
4
IDIOPATHIC PULMONARY FIBROSIS
317 reports
5
DYSPNOEA
259 reports
6
DISEASE PROGRESSION
244 reports
7
MALIGNANT NEOPLASM PROGRESSION
238 reports
8
VOMITING
235 reports
9
WEIGHT DECREASED
216 reports
10
INTERSTITIAL LUNG DISEASE
209 reports